Search

Your search keyword '"NOBUNAGA, M."' showing total 143 results

Search Constraints

Start Over You searched for: Author "NOBUNAGA, M." Remove constraint Author: "NOBUNAGA, M."
143 results on '"NOBUNAGA, M."'

Search Results

106. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.

108. Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factors.

109. Influences of feeding and drinking on circadian rhythms of opioid peptides in plasma, hypothalamus and pituitary gland in rats.

110. [Proposal of revised criteria for malignant rheumatoid arthritis].

114. Serum factors from patients with systemic lupus erythematosus enhancing superoxide generation by normal neutrophils.

115. C1q binding to human vascular smooth muscle cells mediates immune complex deposition and superoxide generation.

116. Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

117. [Antibodies to cytoskeletal systems in patients with adult T-cell leukemia and infectious mononucleosis].

118. Detection of low molecular weight IgM by immunoblot analysis in rheumatoid arthritis.

119. Influences of water deprivation and fasting on hypothalamic, pituitary and plasma opioid peptides and prolactin in rats.

122. [Evaluation of disease activity by hand X-ray findings in rheumatoid arthritis].

123. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.

126. Multiple rheumatoid bursal cysts.

128. Human umbilical cord vein smooth muscle cells lack receptors for C3b and the Fc portion of immunoglobulin G.

130. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria.

133. [Rehabilitation of rheumatoid arthritis (author's transl)].

134. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.

137. [Rheumatism and collagen diseases].

139. [Studies on beta-glucuronidase. II. Clinical application of the assay method of beta-glucuronidase activity using p-nitrophenylglucuronide as the substrate. III. The significance of the serum beta-glucuronidase activity in patients with liver diseases, with special references to its relation with the serum transaminase activity, and to its characteristic behavior in cholangiolitic hepatitis].

142. [A case of G-myeloma].

Catalog

Books, media, physical & digital resources